Antero Midstream Corporation (AM)

Contracted Appalachian midstream generating about $1.15 billion of LTM adjusted EBITDA at roughly 2.8x net leverage, an approximately 8% recurring free-cash-flow yield and a 4.5% distribution covered about 1.8x by free cash flow — but with about 100% revenue concentration in Antero Resources (which owns roughly 29% of the company), a water-handling segment that loses money before a one-time $377 million litigation gain, declining compression, high-pressure gathering and fresh-water volumes, expected Q4 curtailments, neutral-to-cautious sell-side coverage and a fair-not-cheap valuation. Mixed fundamentals: quality infrastructure, undistinguished near-term return profile.

Q3 2026 results (announced, 2026-10-28) are the dominant catalyst and were received two-sided — revenue of $327.0M missed the $340.6M FactSet estimate and EPS came in below consensus, offset by gathering volumes +19%, adjusted EBITDA +3%, more than $400M of debt reduction to roughly 2.8x leverage and $377M of litigation cash received — with a follow-on Wells Fargo price-target raise on the East Side Express pipeline project (announced, 2026-11-02) as the only clean bullish leg. The media sentiment delta is determinate but essentially flat (baseline ≈ -0.02 → scoring ≈ +0.04 over a minimally sampled baseline), retail is mention-only, and the Red-Flag Screen is clean with no cap applied.

Chart scores 2/5: the trend frame is fully bearish and freshly broken, not merely neutral. Price 19.86 closed below every reference average — SMA20 20.82, SMA50 21.26, SMA200 21.62, EMA9 20.77, EMA21 20.85, WMA9 20.83, WMA21 20.81, DEMA14 20.73, TEMA14 20.73 and the daily VWAP 20.31 — and below the 20.94 prior close by 5.2% after a 4.63M-share session versus a ~3.5-4.0M recent pace, i.e. distribution on the break rather than a quiet drift. Momentum agrees with the trend rather than contradicting it: RSI14 38.02 is weak but not capitulation-oversold, Williams %R -89.96 shows the close pinned at the bottom of the 14-day range, and MACD has rolled back over (line -0.10 versus signal -0.09, histogram flipping to -0.01) after a brief mid-October improvement. ADX14 20.50 is direction-agnostic and reads as only a mild trend, which is the sole mitigating element, together with the fact that the 19.625-19.63 low retested the 2026-10-15 low of 19.61 — a support test, but an unconfirmed one with no bullish reversal bar. Volatility (ATR14 0.65 = 3.27% of price, StdDev20 0.41) is normal and tradable. No tradable setup survives: a pullback/oversold LIMIT is barred by the trend-alignment gate (price < SMA50 with MACD < 0, and additionally price under a declining SMA200 with SMA50 < SMA200 and no momentum reclaim), and a breakout STOP above the settled 2026-11-03 high 21.44 prices R/R 0.67 against the structural stop 19.50 — under the 1.00 floor. Chart quality alone therefore caps the trade at Do Nothing.